Dr Reddys Laboratories Ltd gained for a fifth straight session today. The stock is quoting at Rs 1287.7, up 0.02% on the day ...

Dr. Reddy's Laboratories Ltd. closed 8.46% below its 52-week high of 1,420.20 rupees, which the company reached on August 21st.

Dr Reddy's Laboratories plans to launch a cheaper copycat version of Novo Nordisk's blockbuster weight-loss drug Wegovy in 87 ...

Hyderabad: Dr. Reddy’s Laboratories Ltd has announced an investment of Rs 565.4 crore in its step-down wholly owned ...

Indian generic drugs maker Dr Reddy's Laboratories posted a narrow miss of quarterly profit expectations on Wednesday, as it ...

India’s Dr Reddy’s Laboratories Ltd. is gearing up to launch a generic version of semaglutide — the active ingredient in Novo ...

Dr Reddy's Laboratories share price gained almost 3% in the morning trades on Thursday post Q1 results that were declared ...

Indian pharmaceutical companies Sun Pharma, Lupin, and Dr Reddy's Laboratories are conducting recalls in the US due to ...

The company is going to announce results for the quarter ended June 30th, 2025 on July 23, 2025 after the board meeting.

The latest update is out from Dr Reddy’s Laboratories ( (RDY) ).

Dr. Reddy's Laboratories Ltd. closed 11.70% short of its 52-week high of 1,420.20 rupees, which the company reached on August 21st.

Dr Reddy's Laboratories has no upcoming dividends reported. The last reported dividend for Dr Reddy's Laboratories (RDY) was $0.48 and was paid out on August 12, 2024.